370 related articles for article (PubMed ID: 36131163)
1. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
[TBL] [Abstract][Full Text] [Related]
2. Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Chen X; Chen Y; Chen H; Zhu J; Huang R; Xie J; Zhang T; Xie A; Li Y
Abdom Radiol (NY); 2023 Aug; 48(8):2525-2536. PubMed ID: 37169988
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided hepatocellular carcinoma detection on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging using a convolutional neural network: Feasibility evaluation with multi-sequence data.
Cho Y; Han YE; Kim MJ; Park BJ; Sim KC; Sung DJ; Han NY; Park YS
Comput Methods Programs Biomed; 2022 Oct; 225():107032. PubMed ID: 35930863
[TBL] [Abstract][Full Text] [Related]
4. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
5. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
6. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
7. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-based radiomics analysis of preoperative functional liver reserve with MRI and CT image.
Zhu L; Wang F; Chen X; Dong Q; Xia N; Chen J; Li Z; Zhu C
BMC Med Imaging; 2023 Jul; 23(1):94. PubMed ID: 37460944
[TBL] [Abstract][Full Text] [Related]
9. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma.
Mao Y; Wang J; Zhu Y; Chen J; Mao L; Kong W; Qiu Y; Wu X; Guan Y; He J
Hepatobiliary Surg Nutr; 2022 Feb; 11(1):13-24. PubMed ID: 35284527
[TBL] [Abstract][Full Text] [Related]
12. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
13. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract][Full Text] [Related]
14. Five machine learning-based radiomics models for preoperative prediction of histological grade in hepatocellular carcinoma.
Wu C; Du X; Zhang Y; Zhu L; Chen J; Chen Y; Wei Y; Liu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15103-15112. PubMed ID: 37624395
[TBL] [Abstract][Full Text] [Related]
15. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
16. Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma.
Kim S; Shin J; Kim DY; Choi GH; Kim MJ; Choi JY
Clin Cancer Res; 2019 Jul; 25(13):3847-3855. PubMed ID: 30808773
[TBL] [Abstract][Full Text] [Related]
17. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma.
Hu X; Li C; Wang Q; Wu X; Chen Z; Xia F; Cai P; Zhang L; Fan Y; Ma K
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766518
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
Zhang C; Ma LD; Zhang XL; Lei C; Yuan SS; Li JP; Geng ZJ; Li XM; Quan XY; Zheng C; Geng YY; Zhang J; Zheng QL; Hou J; Xie SY; Lu LH; Xie CM
J Magn Reson Imaging; 2024 Jul; 60(1):231-242. PubMed ID: 37888871
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
Yang X; Yuan C; Zhang Y; Wang Z
Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]